BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25317421)

  • 1. In vivo protection against strychnine toxicity in mice by the glycine receptor agonist ivermectin.
    Maher A; Radwan R; Breitinger HG
    Biomed Res Int; 2014; 2014():640790. PubMed ID: 25317421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycine receptor mechanism elucidated by electron cryo-microscopy.
    Du J; Lü W; Wu S; Cheng Y; Gouaux E
    Nature; 2015 Oct; 526(7572):224-9. PubMed ID: 26344198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ivermectin on convulsions in rats produced by lidocaine and strychnine.
    Trailović SM; Varagić VM
    Vet Res Commun; 2007 Oct; 31(7):863-72. PubMed ID: 17308985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDL 27,531 selectively reverses strychnine-induced seizures in mice.
    Kehne JH; Kane JM; Miller FP; Ketteler HJ; Braun DL; Senyah Y; Chaney SF; Abdallah A; Dudley MW; Ogden AM
    Br J Pharmacol; 1992 Aug; 106(4):910-6. PubMed ID: 1327393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivermectin, an unconventional agonist of the glycine receptor chloride channel.
    Shan Q; Haddrill JL; Lynch JW
    J Biol Chem; 2001 Apr; 276(16):12556-64. PubMed ID: 11278873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational transitions and allosteric modulation in a heteromeric glycine receptor.
    Gibbs E; Klemm E; Seiferth D; Kumar A; Ilca SL; Biggin PC; Chakrapani S
    Nat Commun; 2023 Mar; 14(1):1363. PubMed ID: 36914669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycinergic inhibition in thalamus revealed by synaptic receptor blockade.
    Ghavanini AA; Mathers DA; Puil E
    Neuropharmacology; 2005 Sep; 49(3):338-49. PubMed ID: 15993440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant and adverse effects of avermectin analogs in mice are mediated through the gamma-aminobutyric acid(A) receptor.
    Dawson GR; Wafford KA; Smith A; Marshall GR; Bayley PJ; Schaeffer JM; Meinke PT; McKernan RM
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1051-60. PubMed ID: 11082440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcophine and (7S, 8R)-dihydroxydeepoxysarcophine from the Red Sea soft coral Sarcophyton glaucum as in vitro and in vivo modulators of glycine receptors.
    Saleh HA; Raafat KM; Temraz TA; Noureldin N; Breitinger HG; Breitinger U
    Neurotoxicology; 2020 Sep; 80():105-111. PubMed ID: 32702364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrinsic factors regulate partial agonist efficacy of strychnine-sensitive glycine receptors.
    Farroni JS; McCool BA
    BMC Pharmacol; 2004 Aug; 4():16. PubMed ID: 15301692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermodynamics of agonist and antagonist interaction with the strychnine-sensitive glycine receptor.
    Ruiz-Gómez A; García-Calvo M; Vázquez J; Marvizón JC; Valdivieso F; Mayor F
    J Neurochem; 1989 Jun; 52(6):1775-80. PubMed ID: 2542450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic inhibition of glycinergic transmission in vitro and in vivo by flavonoids and strychnine.
    Raafat K; Breitinger U; Mahran L; Ayoub N; Breitinger HG
    Toxicol Sci; 2010 Nov; 118(1):171-82. PubMed ID: 20719748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection via strychnine-sensitive glycine receptors during post-ischemic recovery of excitatory synaptic transmission in the hippocampus.
    Tanabe M; Nitta A; Ono H
    J Pharmacol Sci; 2010; 113(4):378-86. PubMed ID: 20668364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylalanine derivatives with modulating effects on human α1-glycine receptors and anticonvulsant activity in strychnine-induced seizure model in male adult rats.
    Sadek B; Oz M; Nurulain SM; Jayaprakash P; Latacz G; Kieć-Kononowicz K; Szymańska E
    Epilepsy Res; 2017 Dec; 138():124-131. PubMed ID: 28554717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective actions of 1-aminocyclopropanecarboxylic acid (ACPC): a partial agonist at strychnine-insensitive glycine sites.
    Fossom LH; Von Lubitz DK; Lin RC; Skolnick P
    Neurol Res; 1995 Aug; 17(4):265-9. PubMed ID: 7477740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glycine and other inhibitory amino acid neurotransmitters on strychnine convulsive threshold in mice.
    Sangiah S
    Vet Hum Toxicol; 1985 Apr; 27(2):97-9. PubMed ID: 3922104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avermectin B1a inhibits the binding of strychnine to the glycine receptor of rat spinal cord.
    Graham D; Pfeiffer F; Betz H
    Neurosci Lett; 1982 Apr; 29(2):173-6. PubMed ID: 6283439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist action of taurine on glycine receptors in rat supraoptic magnocellular neurones: possible role in osmoregulation.
    Hussy N; Deleuze C; Pantaloni A; Desarménien MG; Moos F
    J Physiol; 1997 Aug; 502 ( Pt 3)(Pt 3):609-21. PubMed ID: 9279812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the hypertension drug niflumic acid as a glycine receptor inhibitor.
    Ito D; Kawazoe Y; Sato A; Uesugi M; Hirata H
    Sci Rep; 2020 Aug; 10(1):13999. PubMed ID: 32814817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of neurosteroid allopregnanolone biosynthesis in the rat spinal cord by glycine and the alkaloidal analogs strychnine and gelsemine.
    Venard C; Boujedaini N; Belon P; Mensah-Nyagan AG; Patte-Mensah C
    Neuroscience; 2008 Apr; 153(1):154-61. PubMed ID: 18367344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.